PMOS Research Observatory

Explore PMOS Research

Search 20,708 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.

20,708 articles match

Total citations

289,983

Peak year

2025(3,021 articles)

Avg citations / article

14

Publications per year

All countries

Topics

All research areas ⓘ

Endocrinology & Hormones12,848
Metabolic Health10,508
Fertility & Reproduction6,468
Epidemiology & Public Health3,913
Pharmacology & Treatment2,800
Genetics & Genomics2,441
Diagnostics & Phenotyping2,345
Mental Health & Psychology1,933

Countries

All countries

China3,806
United States2,435
India1,743
Iran1,194
Turkey922
United Kingdom754
Australia615
Italy475

Top journals

All filters

Fertility and Sterility584
Endocrine Abstracts510
Gynecological Endocrinology400
Frontiers in Endocrinology369
Figshare340
Journal of the Endocrine Society328
Human Reproduction275
Research Square (Research Square)270
PubMed258
The Journal of Clinical Endocrinology & Metabolism223

Top institutions

All filters

Monash University323
Tehran University of Medical Sciences234
Shanghai Jiao Tong University228
Shahid Beheshti University of Medical Sciences221
Peking University212
Shandong University177
Karolinska Institutet167
Peking University Third Hospital166
Monash Health165
University of Adelaide156

Where in the world is each topic being researched?

Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.

HormonesMetabolicFertilityEpidemiol.PharmaGeneticsDiagnos.MentalNutritionMolecularCell BioInflamm.LifestyleMicrobiomeDermatol.
China1.00.91.01.01.11.60.60.31.01.92.01.10.51.60.1
United States1.01.11.11.30.80.91.11.40.50.70.60.71.20.71.3
India0.90.90.90.90.91.12.11.11.30.80.60.80.90.91.8
Iran1.00.90.90.91.60.70.51.11.90.71.02.00.80.70.8
Turkey1.31.20.90.60.40.51.40.90.70.50.61.60.41.11.7
United Kingdom0.91.00.91.31.00.70.92.10.80.60.40.72.00.41.3
Australia0.81.10.91.71.20.60.82.10.80.30.30.13.70.50.6
Italy1.11.21.00.80.90.51.10.81.40.40.30.61.01.11.6
Egypt1.00.81.90.52.00.30.90.60.80.60.41.10.40.21.7
Poland1.31.40.60.60.30.70.61.21.10.50.21.11.21.51.4
Under-specialised
Specialised|RCA > 1 = country focuses on this topic more than average

Studies10,841–10,860 of 20,708

All studies

Concise debate on the consequence of the Petroleum Ether mine of the Alovevera Gel in the PCOS mold

2022Zenodo (CERN European Organization for Nuclear Research)DOI ↗
Endocrinology & HormonesMetabolic HealthNutrition & Diet

Lead Identification from the Phytoconstituents of Cadaba fruticosa (L.) Druce for the Treatment of PCOS: A Computational Approach

2022DOI ↗
Endocrinology & HormonesMetabolic HealthMolecular Mechanisms

Role of Insulin-Sensitizing Drugs in PCOS Management

2022DOI ↗
Endocrinology & HormonesMetabolic HealthPharmacology & Treatment

Risk prediction of gestational diabetes mellitus in women with polycystic ovary syndrome based on a nomogram model

2022DOI ↗
Epidemiology & Public HealthFertility & ReproductionMetabolic HealthGestational Diabetes

PMON206 Pregnancy Rate and Outcomes Following a Randomized Controlled Three-component Lifestyle Intervention in Women with PCOS

2022Journal of the Endocrine SocietyDOI ↗
Fertility & ReproductionMetabolic HealthPharmacology & TreatmentGestational Diabetes

Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?

2022Biomedical reportsDOI ↗
Genetics & GenomicsPharmacology & Treatment

Managing PCOS in the Adolescent

2022DOI ↗
Fertility & ReproductionMetabolic HealthPharmacology & Treatment

PECULIARITIES OF COVID-19 SUSCEPTIBILITY IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

2022ГРААЛЬ НАУКИDOI ↗
Epidemiology & Public HealthFertility & ReproductionMetabolic HealthCardiovascular Disease

Polycystic Ovary Syndrome: Its Genetics and Treatments

2022INDIAN JOURNAL OF PHYSIOLOGY AND ALLIED SCIENCESDOI ↗
Endocrinology & HormonesFertility & ReproductionMetabolic Health

The Diagnostic Importance of Anti-Mullerian Hormone in Predicting Polycystic Ovary Syndrome among Women of Reproductive Age

2022International Journal of Science and Research (IJSR)DOI ↗
Diagnostics & PhenotypingEndocrinology & HormonesFertility & Reproduction

Expression data for PCOS candidate genes in bovine ovaries across gestation

2022FigshareDOI ↗
Endocrinology & HormonesFertility & ReproductionGenetics & Genomics

The Role of Anti-Mullerian Hormone and Other Correlates in Patients with Polycystic Ovary Syndrome

2022Research Square (Research Square)DOI ↗
Diagnostics & PhenotypingEndocrinology & Hormones

Circulating anti-müllerian hormone in a cohort-study of women with severe obesity with and without polycystic ovary syndrome and the effect of a one-year weight loss intervention

2022Research Square (Research Square)DOI ↗
Diagnostics & PhenotypingEpidemiology & Public HealthMetabolic Health

Polycystic Ovarian Syndrome (PCOS)

2022DOI ↗
Diagnostics & PhenotypingEndocrinology & Hormones

Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population

2022Journal of Obstetrics and GynaecologyDOI ↗
Endocrinology & HormonesGenetics & GenomicsMetabolic Health

Blue Morpho: An international survey investigating differences in emotional and psychosexual wellbeing by ethnicity and birthplace in women with polycystic ovary syndrome

2022Endocrine AbstractsDOI ↗
Endocrinology & HormonesMental Health & Psychology

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills.

2022CureusDOI ↗
Endocrinology & HormonesPharmacology & Treatment

Mild Ovarian Stimulation for Infertility in Women with Polycystic Ovary Syndrome

2022Central Asian Journal of Medical SciencesDOI ↗
Diagnostics & PhenotypingEndocrinology & HormonesFertility & Reproduction

Homocysteine levels in polycystic ovary syndrome (PCOS) patients

2022http://isrctn.com/DOI ↗
Endocrinology & HormonesMetabolic Health

E2 level > 2950 pg/ml on hCG trigger day is an independent predictor for birthweight loss of full-term singletons born after fresh embryo transfers in non-PCOS patients

2022Reproductive Biology and EndocrinologyDOI ↗
Epidemiology & Public HealthFertility & Reproduction
← Prev…541542543544545…Next →